The Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients
Authors:
- Wen-Sheng LiuWLWen-Sheng Liu
- Chien-Hung LinCLChien-Hung Lin
- Ann Charis TanATAnn Charis Tan
- Yen-Ting LaiYLYen-Ting Lai
- Tsung-Yun LiuTLTsung-Yun Liu
- Hsiang-Lin ChanHCHsiang-Lin Chan
- Szu-Yuan LiSzu-Yuan Li
- Chun-Fan ChenCCChun-Fan Chen
- Yung-Tai ChenYCYung-Tai Chen
- Tz-Heng ChenTCTz-Heng Chen
- Fan-Yu ChenFCFan-Yu Chen
- Yang HoYHYang Ho
Open Access
- 3 February 2023
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 11 (3) , 442
Abstract
Erythropoiesis-stimulating agents (ESA) are used to treat anemia in hemodialysis (HD) patients. We investigated the role of inflammation and accumulation of environmental toxins (perfluorinated chemicals (PFCs), such as perfluorooctanoic acid and perfluorooctane sulfonate) in the erythropoietic response of HD patients who receive a fixed monthly continuous erythropoietin receptor activator (CERA) dosage. Forty-five patients underwent three successive phases of ESA treatment for two months each (phase one: 100 µg CERA once monthly; phase two: 50 µg CERA twice monthly; phase three: 100 µg CERA once monthly). Patient data were collected to determine the association of various factors with erythropoietic response (change in hematocrit). Liquid chromatography-tandem mass spectrometry was used to analyze perfluorinated chemicals. Twenty-eight patients exhibited a poor erythropoietic response that was significantly associated with: age > 80 years, initial hematocrit > 36%, glucose > 200 mg/dL, alanine aminotransferase > 21 U/L, c-reactive protein > 1 mg/dL, interleukin−6 > 10 ng/mL, lactate dehydrogenase ≤ 190 U/L, and chloride ≤ 93 mEq/L. There was also a borderline significant association between inflammation and PFCs, although PFCs failed to show any impact on ESA response. Age, glucose, chloride, liver function, and inflammation may be associated with cost-effective fixed CERA dosage administered at an increased frequency.Keywords
Funding Information
- Taipei City Hospital (TPCH-108-27, 10901-62-023, V105C-075, V106C-036, V107C-034, V108C-053, V109C-171, VTA108-V1-2-2, VTA109-V1-2-1, MOST 104-2314-B-010-032-MY3)
- Department of Health of Taipei City Government (TPCH-108-27, 10901-62-023, V105C-075, V106C-036, V107C-034, V108C-053, V109C-171, VTA108-V1-2-2, VTA109-V1-2-1, MOST 104-2314-B-010-032-MY3)
- Taipei Veterans General Hospital (TPCH-108-27, 10901-62-023, V105C-075, V106C-036, V107C-034, V108C-053, V109C-171, VTA108-V1-2-2, VTA109-V1-2-1, MOST 104-2314-B-010-032-MY3)
- Academia Sinica (TPCH-108-27, 10901-62-023, V105C-075, V106C-036, V107C-034, V108C-053, V109C-171, VTA108-V1-2-2, VTA109-V1-2-1, MOST 104-2314-B-010-032-MY3)
- Ministry of Science and Technology in Taiwan (TPCH-108-27, 10901-62-023, V105C-075, V106C-036, V107C-034, V108C-053, V109C-171, VTA108-V1-2-2, VTA109-V1-2-1, MOST 104-2314-B-010-032-MY3)
This publication has 36 references indexed in Scilit:
- Factors Predicting Erythropoietin Resistance among Maintenance Hemodialysis PatientsBlood Purification, 2012
- The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis PatientsThe Scientific World Journal, 2012
- Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID studyNephrology Dialysis Transplantation, 2011
- Thyroid Function and Plasma Concentrations of Polyhalogenated Compounds in Inuit AdultsEnvironmental Health Perspectives, 2009
- Do Perfluoroalkyl Compounds Impair Human Semen Quality?Environmental Health Perspectives, 2009
- Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2009
- Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesisLeukemia & Lymphoma, 2009
- Association Among Serum Perfluoroalkyl Chemicals, Glucose Homeostasis, and Metabolic Syndrome in Adolescents and AdultsDiabetes Care, 2008
- Inflammation and insulin resistanceFEBS Letters, 2007
- Role of uremic toxins in exacerbating anemia in renal failureKidney International, 2001